Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Human anthrax immunoglobulin

EU orphan designation number: EU/3/09/691   
Active ingredient: Human anthrax immunoglobulin
Indication: Treatment of inhalation anthrax disease
Sponsor: Emergent Sales and Marketing Germany GmbH
Walter-Gropius-Str. 17, D-80807 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/11/2009 Orphan Designation EMEA/OD/065/09 (2009)8717 of 05/11/2009